• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】30673

【品名】3',4'-dideoxy-3',4'-didehydrokanamycin B; (2R,3R,4S,5S,6R)-4-amino-2-[((1S,2S,3R,4S,6R)-4,6-diamino-3-[[(2R,3R,6S)-3-amino-6-(aminomethyl)-3,6-dihydro-2H-pyran-2-yl]oxy]-2-hydroxycyclohexyl)oxy]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,5-diol

【CA登记号】

【 分 子 式 】C18H35N5O8

【 分 子 量 】449.5048

【元素组成】C 48.1% H 7.85% N 15.58% O 28.47%

与该中间体有关的原料药合成路线共 1 条

合成路线1

该中间体在本合成路线中的序号:(XII)

The acylation of 3',4'-dideoxy-3',4'-didehydrokanamycin B (XII) with tert-butyl-S-(4,6-dimethylpyrimid-2-yl)thiocarbonate (VIII) as before gives 3,2',6'-tri-N-butoxycarbonyl-3',4'-dideoxy-3',4'-didehydrokanamycin B (XIII), which is acylated again with (X) as before yielding the fully protected 3',4'-didehydrohabekacin (XIV). Partial deprotection of (XIV) with trifluoroacetic acid affords 1-N-(4-benzyloxycarbonylamino-2-hydroxybutyryl)-3',4'-dideoxy-3',4'-didehydrokanamycin B (XV), which is finally debenzylated and reduced by a treatment with H2 over PtO2 in aqueous acetic acid.

1 Serradell, M.N.; Castaner, J.; Blancafort, P.; Habekacin. Drugs Fut 1983, 8, 5, 410.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(VIII) 30669 tert-butyl-S-(4,6-dimethylpyrimid-2-yl)thiocarbonate; O-(tert-butyl) S-(4,6-dimethyl-2-pyrimidinyl) carbonothioate 41840-28-2 C11H16N2O2S 详情 详情
(X) 30671 4-Benzyloxycarbonylamino-2-hydroxybutyric acid N-hydroxysuccinimide ester; Benzyl (3S)-4-[(2,5-dioxo-1-pyrrolidinyl)oxy]-3-hydroxy-4-oxobutylcarbamate C16H18N2O7 详情 详情
(XII) 30673 3',4'-dideoxy-3',4'-didehydrokanamycin B; (2R,3R,4S,5S,6R)-4-amino-2-[((1S,2S,3R,4S,6R)-4,6-diamino-3-[[(2R,3R,6S)-3-amino-6-(aminomethyl)-3,6-dihydro-2H-pyran-2-yl]oxy]-2-hydroxycyclohexyl)oxy]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,5-diol C18H35N5O8 详情 详情
(XIII) 30674 3,2',6'-tri-N-butoxycarbonyl-3',4'-dideoxy-3',4'-didehydrokanamycin B; tert-Butyl (2R,3R,4S,5S,6R)-2-([(1S,2S,3R,4S,6R)-6-amino-4-[(tert-butoxycarbonyl)amino]-3-[((2R,3R,6S)-3-[(tert-butoxycarbonyl)amino]-6-[[(tert-butoxycarbonyl)amino]methyl]-3,6-dihydro-2H-pyran-2-yl)oxy]-2-hydroxycyclohexyl]oxy)-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-ylcarbamate C38H67N5O16 详情 详情
(XIV) 30675 tert-butyl (1S,2R,3S,4S,5R)-2-[[(2R,3R,6S)-3-amino-6-(aminomethyl)-3,6-dihydro-2H-pyran-2-yl]oxy]-5-[((2S)-4-[[(benzyloxy)carbonyl]amino]-2-hydroxybutanoyl)amino]-4-[[(2R,3R,4S,5S,6R)-4-[(tert-butoxycarbonyl)amino]-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy]-3-hydroxycyclohexylcarbamate C40H64N6O16 详情 详情
(XV) 30676 1-N-(4-benzyloxycarbonylamino-2-Hydroxybutyryl)-3',4'-dideoxy-3',4'-didehydrokanamycin B; Benzyl (3S)-4-[((1R,2S,3S,4R,5S)-5-amino-4-[[(2R,3R,6S)-3-amino-6-(aminomethyl)-3,6-dihydro-2H-pyran-2-yl]oxy]-2-[[(2R,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy]-3-hydroxycyclohexyl)amino]-3-hydroxy-4-oxobutylcarbamate C30H48N6O12 详情 详情
Extended Information